Presence and Persistence of HPV 58 Molecular Variations ORF E6 and ORF E7 Among Women With Normal Cytology in the Bogotá, Colombia Cohort

Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010 ;127:2893-917.

https://doi.org/10.1002/ijc.25516

Pardo C, Cendales R. Incidencia estimada y mortalidad por cáncer en Colombia 2002-2006. Bogotá: Instituto Nacional de Cancerología; 2010.

Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005.366:991-8.

https://doi.org/10.1016/S0140-6736(05)67069-9

Molano M, Posso H, Weiderpass E, et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer. 2002;87:324-33.

https://doi.org/10.1038/sj.bjc.6600442

Molano M, Van den Brule AJ, Plummer M, et al. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study. Am J Epidemiol. 2003;158:486-94.

https://doi.org/10.1093/aje/kwg171

Muñoz N, Méndez F, Posso H, et al. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis. 2004;190:2077-87.

https://doi.org/10.1086/425907

Méndez F, Muñoz N, Posso H, et al. Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J Infect Dis. 2005;192:1158-65.

https://doi.org/10.1086/444391

Almonte M, Albero G, Molano M, et al. Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean. Vaccine. 2008;26:L16-36.

https://doi.org/10.1016/j.vaccine.2008.06.008

Villa L, Sichero L, Rahal P, et al. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol. 2000;81:2959-68.

https://doi.org/10.1099/0022-1317-81-12-2959

zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology. 1991;184:9-13.

https://doi.org/10.1016/0042-6822(91)90816-T

Veras VS, Cerqueira DM, Martins CR. L1 sequence of a new human papillomavirus type-58 variant associated with cervical intraepithelial neoplasia. Braz J Med Biol Res. 2005;38:1-4.

https://doi.org/10.1590/S0100-879X2005000100001

Calleja-Macias IE, Villa LL, Prado JC, et al. Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J Virol. 2005;79:13630-40.

https://doi.org/10.1128/JVI.79.21.13630-13640.2005

Chan PK, Lam CW, Cheung TH, et al. Association of human papillomavirus type 58 variant with the risk of cervical cancer. J Natl Cancer Inst. 2002;94:1249-53.

https://doi.org/10.1093/jnci/94.16.1249

Xin CY, Matsumoto K, Yoshikawa H, et al. Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese women with cervical intraepithelial neoplasia/cervical cancer in relation to their oncogenic potential. Cancer Lett. 2001;170:19-24.

https://doi.org/10.1016/S0304-3835(01)00570-5

Kirii Y, Iwamoto S, Matsukura T. Human papillomavirus type 58 ADN sequence. Virology. 1991;185:424-7.

https://doi.org/10.1016/0042-6822(91)90791-9

Jacobs MV, van den Brule AJ, Snijders PJ, et al. A nonradioactive PCR enzyme-immunoassay enables a rapid identification of HPV 16 and 18 in cervical scrapes after GP5+/6+ PCR. J Med Virol. 1996;49:223-9.

https://doi.org/10.1002/(SICI)1096-9071(199607)49:3<223::AID-JMV11>3.0.CO;2-D

van den Brule AJ, Meijer CJ, Bakels V, et al. Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J Clin Microbiol. 1990;28:2739-43.

https://doi.org/10.1128/JCM.28.12.2739-2743.1990

Wu EQ, Zha X, Yu XH, et al. Profile of physical status and gene variation of human papillomavirus 58 genome in cervical cancer. J Gen Virol. 2009;90:1229-37.

https://doi.org/10.1099/vir.0.008227-0

Chang YJ, Chen HC, Lee BH, et al. Unique variants of human papillomavirus genotypes 52 and 58 and risk of cervical neoplasia. Int J Cancer. 2011;129:965-73

https://doi.org/10.1002/ijc.25724

Raiol T, Wyant PS, de Amorim RM, et al. Genetic variability and phylogeny of the high-risk HPV-31, -33, -35, -52, and -58 in central Brazil. J Med Virol. 2009;81:685-92.

https://doi.org/10.1002/jmv.21432

Chan PK, Luk AC, Park JS, et al. Identification of human papillomavirus type 58 lineages and the distribution worldwide. Infect Dis. 2011;203:1565-73.

https://doi.org/10.1093/infdis/jir157

Mayrand MH, Coutlee F, Hankins C, et al. Detection of human papillomavirus type 16 ADN in consecutive genital samples does not always represent persistent infection as determined by molecular variant analysis. J Clin Microbiol. 2000;38:3388-93.

https://doi.org/10.1128/JCM.38.9.3388-3393.2000

Schlecht NF, Burk RD, Palefsky JM, et al. Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women. J Gen Virol. 2005;86:2709-20.

https://doi.org/10.1099/vir.0.81060-0

Da Costa MM, Hogeboom CJ, Holly EA, et al. Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant. J Infect Dis. 2002;185:1229-37.

https://doi.org/10.1086/340125